Research in Pharmaceutical Sciences

ORIGINAL ARTICLE
Year
: 2021  |  Volume : 16  |  Issue : 5  |  Page : 447--454

Chimeric antigen receptor-T cells immunotherapy for targeting breast cancer


Ilnaz Rahimmanesh1, Hossein Khanahmad2 
1 Applied Physiology Research Center, Cardiovascular Research Institute, Isfahan University of Medical Sciences, Isfahan, I.R. Iran
2 Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, I.R. Iran

Correspondence Address:
Hossein Khanahmad
Department of Genetics and Molecular Biology, School of Medicine, Isfahan University of Medical Sciences, Isfahan
I.R. Iran

Redirected chimeric antigen receptor (CAR) T-cells can recognize and eradicate cancer cells in a major histocompatibility complex independent manner. Genetic engineering of T cells through CAR expression has yielded great results in the treatment of hematological malignancies compared with solid tumors. There has been a constant effort to enhance the effectiveness of these living drugs, due to their limited success in targeting solid tumors. Poor T cell trafficking, tumor-specific antigen selection, and the immunosuppressive tumor microenvironment are considered as the main barriers in targeting solid tumors by CAR T-cells. Here, we reviewed the current state of CAR T-cell therapy in breast cancer, as the second cancer-related death in women worldwide, as well as some strategies adopted to keep the main limitations of CAR T-cells under control. Also, we summarized various approaches that have been developed to enhance the therapeutic outcomes of this treatment in solid tumors targeting.


How to cite this article:
Rahimmanesh I, Khanahmad H. Chimeric antigen receptor-T cells immunotherapy for targeting breast cancer.Res Pharma Sci 2021;16:447-454


How to cite this URL:
Rahimmanesh I, Khanahmad H. Chimeric antigen receptor-T cells immunotherapy for targeting breast cancer. Res Pharma Sci [serial online] 2021 [cited 2022 Jan 17 ];16:447-454
Available from: https://www.rpsjournal.net/article.asp?issn=1735-5362;year=2021;volume=16;issue=5;spage=447;epage=454;aulast=Rahimmanesh;type=0